Lymphomatous meningitis

Also known as: Leptomeningeal Metastasis / Neoplastic Meningitis / Leptomeningeal Metastases / Metastatic Malignant Neoplasm to the Leptomeninges / Metastatic Malignant Neoplasm in the Leptomeninges / Leptomeningeal Disease (LMD) / Leptomeningeal Disease / Leptomeningeal Carcinomatosis / Metastatic malignant neoplasm to leptomeninges (disorder) / Lymphomatous meningitis (disorder) / Malignant meningitis (disorder) / Leptomeningeal Neoplasms / Meningeal dissemination / Metastases to meninges / Meningeal Carcinomatosis

DrugDrug NameDrug Description
DB00987CytarabineA pyrimidine nucleoside analogue used to treat acute non-lymphocytic leukemia, lymphocytic leukemia, and the blast phase of chronic myelocytic leukemia.
DrugDrug NamePhaseStatusCount
DB11740Adavosertib1Active Not Recruiting1
DB08916Afatinib1Terminated1
DB11945Avelumab1Active Not Recruiting1
DB00115Cyanocobalamin1Completed1
DB00987Cytarabine1Terminated1
DB00746Deferoxamine1Recruiting1
DB01234Dexamethasone1Completed1
DB00158Folic acid1Completed1
DB06186Ipilimumab1Recruiting1
DB09035Nivolumab1Recruiting2
DB15186Paxalisib1Recruiting1
DB00642Pemetrexed1Completed1
DB05920RTA 7441Terminated2
DB00853Temozolomide1Terminated1
DB01030Topotecan1Completed1
DB17421Trotabresib1Not Yet Recruiting1
DB00361Vinorelbine1Not Yet Recruiting1
DB00112Bevacizumab1 / 2Completed1
DB00115Cyanocobalamin1 / 2Active Not Recruiting1
DB01234Dexamethasone1 / 2Active Not Recruiting1
DB01234Dexamethasone1 / 2Completed1
DB00158Folic acid1 / 2Active Not Recruiting1
DB13982Lutetium Lu-1771 / 2Withdrawn1
DB15635Omburtamab1 / 2Withdrawn1
DB00642Pemetrexed1 / 2Active Not Recruiting1
DB00642Pemetrexed1 / 2Completed1
DB06366Pertuzumab1 / 2Recruiting1
DB00073Rituximab1 / 2Terminated1
DB00072Trastuzumab1 / 2Recruiting1
DB00112Bevacizumab2Completed1
DB00112Bevacizumab2Unknown Status2
DB14776Camrelizumab2Recruiting1
DB01101Capecitabine2Active Not Recruiting1
DB01101Capecitabine2Recruiting1
DB00515Cisplatin2Completed1
DB00531Cyclophosphamide2Terminated1
DB00987Cytarabine2Completed2
DB00987Cytarabine2Terminated1
DB06423Endostatin2Recruiting1
DB15769Envafolimab2Recruiting1
DB00530Erlotinib2Terminated1
DB00773Etoposide2Completed1
DB06186Ipilimumab2Completed1
DB09078Lenvatinib2Terminated1
DB00563Methotrexate2Completed3
DB00563Methotrexate2Recruiting1
DB00563Methotrexate2Terminated1
DB06192Nimotuzumab2Recruiting1
DB09035Nivolumab2Completed1
DB09330Osimertinib2Active Not Recruiting1
DB09330Osimertinib2Unknown Status2
DB09037Pembrolizumab2Terminated1
DB00642Pemetrexed2Not Yet Recruiting2
DB00853Temozolomide2Terminated1
DB05007Tesevatinib2Completed1
DB11973Tesevatinib2Completed1
DB01030Topotecan2Completed1
DB01030Topotecan2Terminated1
DB00072Trastuzumab2Active Not Recruiting1
DB00072Trastuzumab2Recruiting1
DB14962Trastuzumab deruxtecan2Completed1
DB14962Trastuzumab deruxtecan2Recruiting1
DB11652Tucatinib2Active Not Recruiting1
DB11652Tucatinib2Recruiting1
DB17124Omburtamab I-1312 / 3Terminated1
DB14684Calcium polycarbophil3Not Yet Recruiting1
DB01101Capecitabine3Not Yet Recruiting1
DB00987Cytarabine3Completed1
DB08871Eribulin3Not Yet Recruiting1
DB00563Methotrexate3Not Yet Recruiting1
DB06171Paclitaxel trevatide3Not Yet Recruiting1
DB11714Durvalumab4Not Yet Recruiting1
DB06423Endostatin4Not Yet Recruiting1
DB12130Lorlatinib4Not Yet Recruiting1
DB00563Methotrexate4Not Yet Recruiting2
DB16640AlmonertinibNot AvailableNot Yet Recruiting1
DB16640AlmonertinibNot AvailableRecruiting1
DB00112BevacizumabNot AvailableNot Yet Recruiting1
DB00987CytarabineNot AvailableTerminated1
DB00563MethotrexateNot AvailableWithdrawn1
DB09330OsimertinibNot AvailableRecruiting1
DB06171Paclitaxel trevatideNot AvailableNo Longer Available1
DB00642PemetrexedNot AvailableRecruiting2
DB00398SorafenibNot AvailableTerminated1